{'52WeekChange': -0.5539906,
 'SandP52WeekChange': None,
 'address1': '1 Rockefeller Plaza',
 'address2': 'Suite 1039',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.96,
 'askSize': 1300,
 'averageDailyVolume10Day': 1592125,
 'averageVolume': 680441,
 'averageVolume10days': 1592125,
 'beta': None,
 'beta3Year': None,
 'bid': 2.92,
 'bidSize': 1300,
 'bookValue': 0.416,
 'category': None,
 'circulatingSupply': None,
 'city': 'New York',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 3.06,
 'dayLow': 2.8001,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.335,
 'enterpriseToRevenue': None,
 'enterpriseValue': 29017784,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 2.6951427,
 'fiftyTwoWeekHigh': 7.25,
 'fiftyTwoWeekLow': 2.31,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 5779432,
 'forwardEps': -0.47,
 'forwardPE': -6.212766,
 'fromCurrency': None,
 'fullTimeEmployees': 2,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.55335,
 'heldPercentInstitutions': 0.0028400002,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/hoththerapeutics.com',
 'longBusinessSummary': 'Hoth Therapeutics, Inc., a biopharmaceutical company, '
                        'focuses on developing therapies for dermatological '
                        'disorders. The company focuses on therapies for '
                        'patients suffering from indications, including '
                        'eczema, chronic wounds, psoriasis, asthma, and acne. '
                        'It intends to use the BioLexa Platform to develop two '
                        'topical cream products that treat eczema and reduces '
                        'post-procedure infections for patients undergoing '
                        'aesthetic dermatology procedures. The company has '
                        'license agreements with the George Washington '
                        'University; the University of Maryland Baltimore; '
                        'Isoprene Pharmaceuticals, Inc.; the North Carolina '
                        'State University; Zyl√∂ Therapeutics, Inc.; Chelexa '
                        'BioSciences, Inc.; and the University of Cincinnati. '
                        'Hoth Therapeutics, Inc. was founded in 2017 and is '
                        'headquartered in New York, New York.',
 'longName': 'Hoth Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 39186108,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_434856528',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -8701847,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.81,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '646 756 2997',
 'previousClose': 2.85,
 'priceHint': 4,
 'priceToBook': 7.019231,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 3.06,
 'regularMarketDayLow': 2.8001,
 'regularMarketOpen': 2.81,
 'regularMarketPreviousClose': 2.85,
 'regularMarketPrice': 2.81,
 'regularMarketVolume': 1157841,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 13419900,
 'sharesPercentSharesOut': 0.0198,
 'sharesShort': 265227,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 338668,
 'shortName': 'Hoth Therapeutics, Inc.',
 'shortPercentOfFloat': 0.026300002,
 'shortRatio': 0.59,
 'startDate': None,
 'state': 'NY',
 'strikePrice': None,
 'symbol': 'HOTH',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.872,
 'twoHundredDayAverage': 3.5819066,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'ff6dafe1-fa0d-3a83-9121-424872ea93bf',
 'volume': 1157841,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.hoththerapeutics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '10020'}